Scientists at the University of New Mexico have developed a groundbreaking vaccine that targets the tau protein—a toxic buildup inside neurons widely believed to cause memory loss and cognitive decline in Alzheimer’s patients. Unlike current treatments that only slow symptoms, this vaccine activates the immune system to find and destroy tau tangles before they can do damage.

In preclinical trials, genetically engineered mice showed a dramatic reduction in tau deposits and preserved brain function longer than expected. With human trials on the horizon, researchers hope this could shift the fight against Alzheimer’s from reactive to preventive — a future where memory loss might be stopped before it starts.